by William Jester | Dec 22, 2021 | Community, Covid, News
An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck MRK -0.74% & Co. and partner Ridgeback Biotherapeutics LP. The panel, known as the...
by Pamela Dahlen | Dec 21, 2021 | Community, Covid, News
NEJM Catalyst Innovations in Care Delivery The health inequities revealed by the Covid-19 pandemic, along with heightened awareness of racial justice issues, present opportunities for leaders, especially at community-based health centers, to engage with, listen to,...
by William Jester | Dec 21, 2021 | Community, Covid, News
With the spread of the COVID-19 Omicron variant, investors across the country have seen substantial hits to their portfolios. Richard Michelfelder, a clinical associate professor in the Rutgers–Camden School of Business whose research focuses on regulation, utility...
by Pamela Dahlen | Dec 20, 2021 | Community, Covid, News
If you’re struggling to “wait and see” how bad omicron might be, here are productive ways to cope. Read the Full Article.
by Pamela Dahlen | Dec 19, 2021 | Community, News
With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone’s prescription-only status. This would make it easier to get the lifesaving drug to people at risk. Read the Full Article.
